Research - News
Cystic fibrosis lung cells were restored to 50 percent of healthy function in work that provides the first evidence that novel therapeutic strategies for human patients can be identified based on yeast studies.
UAB engineering professor Dean Sicking’s SAFER Barriers will be installed at the historic Le Mans Race Circuit.
Big data provides insight into patient readmission after pediatric neurosurgery.
Researchers from UAB, Emory and Microsoft demonstrate that HIV has evolved to be pre-adapted to the immune response, worsening clinical outcomes in newly infected patients.
UAB researchers will use a $1.8 million grant to look at single cells for altered expression of the interferon gamma receptor gene.
VA Research support for UAB clinicians and scientists has been important for six decades.
Longtime VP for Research and Economic Development Richard B. Marchase, Ph.D., plans to retire at the end of 2016. During his tenure, UAB annual research expenditures grew from $331 million to $510 million.
A treatment used for depression, Parkinson’s disease and autism shows promise to alleviate obesity in binge-eating disorder patients.
Results show that JAK/STAT pathway inhibitors may be a new class of therapeutic treatments for patients with Parkinson’s disease. Acting by reducing inflammation, they prevent neurodegeneration in animal models and may be an important new approach to slow progression of the disease.
Cutting-edge technology and research brings national attention to UAB.
Understanding how people respond to aspirin is key in terms of knowing who will benefit from it.
The facility will enable new distracted-driving research, addressing a major public health issue that is a leading cause of highway and traffic-related injuries and death.
The UAB Division of Rheumatology and Immunology and the Division of Cardiovascular Disease look at effects of Allopurinol in healthy adults age 18-40.

Researchers have proposed a model that resolves a seeming paradox in one of the most intriguing areas of the brain, exploring how immature granule cells in the dentate gyrus appear able to enhance pattern separation due to lesser synaptic connectivity than mature cells.

UAB professor leads study in Brazil to help further understand the effects of Zika virus during pregnancy.
Customized deep-coverage, next-generation sequencing will replace the current state-of-the-art approach.
UAB’s new REACT Center is the national coordinating center for six centers designed to promote research and train scientists and clinicians in the medical rehabilitation field.
UAB researchers uncover new information about drivers’ likelihood to participate in risky roadway behavior.
An international clinical trial for a new HIV antibody, VRC01 begins in late spring at UAB as part of the Antibody Mediated Prevention study.
A resuscitation study found another small step to help improve out-of-hospital cardiac arrest survival.
Research funding awarded to evaluate the effectiveness of disease-specific outcomes of patients using biologic therapies.
The innate immune systems of plants and plant pathogens are in a biological arms race, and if plants lose, food sources may diminish. Mukhtar probes the genetics and molecular mechanisms of plant immunity.
UAB statistician and multi-institution team discuss common statistical errors in obesity research and how to avoid them.
UAB researchers use novel approach with historic film to discover just how endangered Kemp’s ridley sea turtles are.
This mass spectrometry method can locate where molecular changes occur in a thin slice of tissue, and it has broad applicability to biomedical research.
UAB hosted over 200 surgeons and hospital administrators in a seminar about the growth and future of robotic surgery
Part of the challenge is to do a better job of helping patients make their own, well-informed choices.
UAB assistant professor leads the way in providing therapy for HIV patients with chronic pain.
Couples needed for study on the prevention of bacterial vaginosis between women and their male counterparts.
The March 28 event aims to identify novel potential therapies and discuss new approaches to repair damaged hearts and vasculature.
Page 39 of 62